Clinical Trials · NCT00332696
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novartis Pharmaceuticals
- Enrollment
- 64
- Start date
- Sep 2005
- Locations
- 1 site, France
- Primary endpoint
- Number of Participants With Treatment Success From Day 10 to Day 13